Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29 Suppl 8, p.viii165 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | viii165 |
| container_title | Annals of oncology |
| container_volume | 29 Suppl 8 |
| creator | Buchler, T Fiala, O Veskrnova, V Chloupkova, R Poprach, A Kiss, I Kopeckova, K Dusek, L Slavicek, L Kohoutek, M Finek, J Svoboda, M Dvorak, J Petruzelka, L B Melichar, B |
| description | |
| doi_str_mv | 10.1093/annonc/mdy281.038 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy281_038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32136289</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1788-44d87d41284ed59d907d94f27af6de8e4756d4f9c4f753e1ad83bbff8717df353</originalsourceid><addsrcrecordid>eNo9Udtq3DAQFSWh2Vw-IC9FP-CNZMm21LcQssnCQqA0z0aWRq2CLRlJW_B_5QMjZ9s-DXNmzpnhHIRuKdlSItmd8j54fTeZpRZ0S5j4gja0aWUlCKdnaENkzaquYfwCXab0RghpZS2_ogtWU9bWQm7Q-36alc44WGxgVAsYrIxx2QW_YspnVz0-7X7gKfigx-DV-AkOwThIuGzl34DDMeswwcqwLqZcjc7DOolqXrDzeIKsUlbZaazDGCLoXIS08hoingsOPqfv-B5HyDGkuczdHyjdL5dyXKpBpfWzcn1JLl2jc6vGBDd_6xV63T3-fHiuDi9P-4f7Q6VpJ0TFuRGd4bQWHEwjjSSdkdzWnbKtAQG8a1rDrdTcFpOAKiPYMFgrOtoZyxp2hehJV5efUgTbz9FNKi49Jf2aQH9KoD8l0JcECufbiTMfhwnMf8Y_y9kH6RiJrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Buchler, T ; Fiala, O ; Veskrnova, V ; Chloupkova, R ; Poprach, A ; Kiss, I ; Kopeckova, K ; Dusek, L ; Slavicek, L ; Kohoutek, M ; Finek, J ; Svoboda, M ; Dvorak, J ; Petruzelka, L B ; Melichar, B</creator><creatorcontrib>Buchler, T ; Fiala, O ; Veskrnova, V ; Chloupkova, R ; Poprach, A ; Kiss, I ; Kopeckova, K ; Dusek, L ; Slavicek, L ; Kohoutek, M ; Finek, J ; Svoboda, M ; Dvorak, J ; Petruzelka, L B ; Melichar, B</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy281.038</identifier><identifier>PMID: 32136289</identifier><language>eng</language><publisher>England</publisher><ispartof>Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii165</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32136289$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buchler, T</creatorcontrib><creatorcontrib>Fiala, O</creatorcontrib><creatorcontrib>Veskrnova, V</creatorcontrib><creatorcontrib>Chloupkova, R</creatorcontrib><creatorcontrib>Poprach, A</creatorcontrib><creatorcontrib>Kiss, I</creatorcontrib><creatorcontrib>Kopeckova, K</creatorcontrib><creatorcontrib>Dusek, L</creatorcontrib><creatorcontrib>Slavicek, L</creatorcontrib><creatorcontrib>Kohoutek, M</creatorcontrib><creatorcontrib>Finek, J</creatorcontrib><creatorcontrib>Svoboda, M</creatorcontrib><creatorcontrib>Dvorak, J</creatorcontrib><creatorcontrib>Petruzelka, L B</creatorcontrib><creatorcontrib>Melichar, B</creatorcontrib><title>Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNo9Udtq3DAQFSWh2Vw-IC9FP-CNZMm21LcQssnCQqA0z0aWRq2CLRlJW_B_5QMjZ9s-DXNmzpnhHIRuKdlSItmd8j54fTeZpRZ0S5j4gja0aWUlCKdnaENkzaquYfwCXab0RghpZS2_ogtWU9bWQm7Q-36alc44WGxgVAsYrIxx2QW_YspnVz0-7X7gKfigx-DV-AkOwThIuGzl34DDMeswwcqwLqZcjc7DOolqXrDzeIKsUlbZaazDGCLoXIS08hoingsOPqfv-B5HyDGkuczdHyjdL5dyXKpBpfWzcn1JLl2jc6vGBDd_6xV63T3-fHiuDi9P-4f7Q6VpJ0TFuRGd4bQWHEwjjSSdkdzWnbKtAQG8a1rDrdTcFpOAKiPYMFgrOtoZyxp2hehJV5efUgTbz9FNKi49Jf2aQH9KoD8l0JcECufbiTMfhwnMf8Y_y9kH6RiJrg</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Buchler, T</creator><creator>Fiala, O</creator><creator>Veskrnova, V</creator><creator>Chloupkova, R</creator><creator>Poprach, A</creator><creator>Kiss, I</creator><creator>Kopeckova, K</creator><creator>Dusek, L</creator><creator>Slavicek, L</creator><creator>Kohoutek, M</creator><creator>Finek, J</creator><creator>Svoboda, M</creator><creator>Dvorak, J</creator><creator>Petruzelka, L B</creator><creator>Melichar, B</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis</title><author>Buchler, T ; Fiala, O ; Veskrnova, V ; Chloupkova, R ; Poprach, A ; Kiss, I ; Kopeckova, K ; Dusek, L ; Slavicek, L ; Kohoutek, M ; Finek, J ; Svoboda, M ; Dvorak, J ; Petruzelka, L B ; Melichar, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1788-44d87d41284ed59d907d94f27af6de8e4756d4f9c4f753e1ad83bbff8717df353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buchler, T</creatorcontrib><creatorcontrib>Fiala, O</creatorcontrib><creatorcontrib>Veskrnova, V</creatorcontrib><creatorcontrib>Chloupkova, R</creatorcontrib><creatorcontrib>Poprach, A</creatorcontrib><creatorcontrib>Kiss, I</creatorcontrib><creatorcontrib>Kopeckova, K</creatorcontrib><creatorcontrib>Dusek, L</creatorcontrib><creatorcontrib>Slavicek, L</creatorcontrib><creatorcontrib>Kohoutek, M</creatorcontrib><creatorcontrib>Finek, J</creatorcontrib><creatorcontrib>Svoboda, M</creatorcontrib><creatorcontrib>Dvorak, J</creatorcontrib><creatorcontrib>Petruzelka, L B</creatorcontrib><creatorcontrib>Melichar, B</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buchler, T</au><au>Fiala, O</au><au>Veskrnova, V</au><au>Chloupkova, R</au><au>Poprach, A</au><au>Kiss, I</au><au>Kopeckova, K</au><au>Dusek, L</au><au>Slavicek, L</au><au>Kohoutek, M</au><au>Finek, J</au><au>Svoboda, M</au><au>Dvorak, J</au><au>Petruzelka, L B</au><au>Melichar, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29 Suppl 8</volume><spage>viii165</spage><pages>viii165-</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pmid>32136289</pmid><doi>10.1093/annonc/mdy281.038</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii165 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy281_038 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Impact of delayed addition of anti-EGFR monoclonal antibodies on the outcome of first-line therapy in metastatic colorectal cancer patients: A retrospective registry-based analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T12%3A51%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20delayed%20addition%20of%20anti-EGFR%20monoclonal%20antibodies%20on%20the%20outcome%20of%20first-line%20therapy%20in%20metastatic%20colorectal%20cancer%20patients:%20A%20retrospective%20registry-based%20analysis&rft.jtitle=Annals%20of%20oncology&rft.au=Buchler,%20T&rft.date=2018-10&rft.volume=29%20Suppl%208&rft.spage=viii165&rft.pages=viii165-&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy281.038&rft_dat=%3Cpubmed_cross%3E32136289%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32136289&rfr_iscdi=true |